StockMarketWire.com - UBS today upgrades its investment rating on Synthomer [LON:SYNT] to neutral (from sell) and cut its price target to 310p (from 326p).

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk